Breakthrough infection after two vaccines produced more robust circulating IgA responses than a third vaccine dose (median OD ± IQR, 1.24, 1.11–1.41 vs. 0.63, 0.34–1.06, p = 0.0003, Figure 3a). This evidence concerns the gene CD79A and infection.